Dr Daisy Shu has received the prestigious BrightFocus Foundation New Investigator Grant to advance groundbreaking research into Age-Related Macular Degeneration - a leading cause of vision loss worldwide.
We are thrilled to announce that Dr Daisy Shu has been awarded the prestigious BrightFocus Foundation New Investigator Grant in Macular Degeneration Research, a major international grant supporting innovative research into the causes, prevention, and treatment of Age-Related Macular Degeneration (AMD) - a leading cause of vision loss globally.
Daisy鈥檚 project, titled 鈥淔rom Fumarates to Microtubules: Novel Anti-Angiogenic and Anti-Fibrotic Therapies for AMD,鈥聽explores innovative therapeutic strategies that target the underlying mechanisms of AMD. Her work promises to open new avenues for treatment by addressing both abnormal blood vessel growth and fibrotic scarring - two major contributors to vision deterioration in AMD patients.
The聽BrightFocus Foundation聽awards this grant through a highly competitive process, selecting only the most promising and impactful research proposals. Projects are evaluated by a panel of leading scientists and clinicians, with a focus on innovation, scientific merit, and potential to advance the field of macular degeneration research.
This award is a testament to the bold, outside-the-box nature of her research and its potential to significantly impact the field. Her success is a testament to the power of curiosity, innovation, and perseverance in the fight against vision loss.
Congratulations Daisy!